{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:13:19Z","timestamp":1790446399196,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1053\/j.semdp.2011.02.010","type":"journal-article","created":{"date-parts":[[2011,7,10]],"date-time":"2011-07-10T16:38:15Z","timestamp":1310315895000},"page":"245-255","source":"Crossref","is-referenced-by-count":33,"title":["Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers"],"prefix":"10.1053","volume":"28","author":[{"given":"Birgitta","family":"Sander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2011.02.010_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bjc.1980.27","article-title":"Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes)","volume":"41","author":"Tolksdorf","year":"1980","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib2","first-page":"181","article-title":"Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity","volume":"113","author":"Swerdlow","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00000478-199008000-00007","article-title":"Lymphocytic lymphoma of intermediate differentiation","volume":"14","author":"Lardelli","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib5","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.semdp.2011.02.010_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","article-title":"Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period","volume":"6","author":"Norton","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib8","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.11096","article-title":"Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma","volume":"97","author":"Romaguera","year":"2003","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2559.1984.tb02377.x","article-title":"Multiple lymphomatous polyposis of the gastrointestinal tract","volume":"8","author":"Isaacson","year":"1984","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.02.010_bib11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0016-5085(94)90558-4","article-title":"Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine","volume":"107","author":"Pals","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semdp.2011.02.010_bib12","first-page":"919","article-title":"Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas","volume":"150","author":"Drillenburg","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/asheducation-2009.1.542","article-title":"Current treatment standards and emerging strategies in mantle cell lymphoma","author":"Dreyling","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.semdp.2011.02.010_bib14","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00000478-200608000-00004","article-title":"Mantle cell lymphoma with plasma cell differentiation","volume":"30","author":"Young","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/PAS.0b013e3182049a9c","article-title":"Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component","volume":"35","author":"Visco","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib21","first-page":"326","article-title":"Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23","volume":"7","author":"Dorfman","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib22","first-page":"925","article-title":"Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma","volume":"9","author":"Kumar","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1309\/UQ4N-M5KL-0ANY-YD3G","article-title":"Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"116","author":"Gong","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/XV4AG7EMWQU7ER67","article-title":"CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases","volume":"120","author":"Schlette","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1309\/R94MAFJY5EA4A8C3","article-title":"CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease","volume":"130","author":"Kelemen","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.855","article-title":"The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL","volume":"26","author":"Barna","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib28","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib29","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2011.02.010_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.2008.07329.x","article-title":"The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival","volume":"143","author":"Wang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib34","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","article-title":"Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma","volume":"94","author":"Dictor","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.2009.140","article-title":"Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms","volume":"23","author":"Chen","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib38","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.81.13.4144","article-title":"The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus","volume":"81","author":"Erikson","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.02.010_bib39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V76.7.1387.1387","article-title":"Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus","volume":"76","author":"Williams","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/path.1711630104","article-title":"Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage","volume":"163","author":"Vandenberghe","year":"1991","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib41","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","article-title":"PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma","volume":"88","author":"Rosenberg","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.02.010_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2141.1993.tb03194.x","article-title":"Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation","volume":"85","author":"Komatsu","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib43","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.leu.2403459","article-title":"Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma","volume":"18","author":"Wlodarska","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.02.010_bib44","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1080\/10428190701402903","article-title":"Characterization of genetic changes in MCL by interphase FISH on tissue sections","volume":"48","author":"Sander","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.02.010_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.leu.2403340","article-title":"Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia","volume":"18","author":"van der Burg","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.02.010_bib46","first-page":"2159","article-title":"BCL-1\/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation","volume":"9","author":"Lukas","year":"1994","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2011.02.010_bib47","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood.V83.12.3689.3689","article-title":"Rearrangement of CCND1 (BCL1\/PRAD1) 3\u2032 untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.21166","article-title":"Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1","volume":"117","author":"Sander","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib49","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1200\/JCO.2006.08.7999","article-title":"Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors","volume":"25","author":"Kienle","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/gcc.1216","article-title":"Unusual case of leukemic mantle cell lymphoma with amplified CCND1\/IGH fusion gene","volume":"33","author":"Gruszka-Westwood","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib51","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib52","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"10.1053\/j.semdp.2011.02.010_bib53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2008-03-142182","article-title":"Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma","volume":"112","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib54","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4161\/cc.8.21.9993","article-title":"3' UTR mediated regulation of the cyclin D1 proto-oncogene","volume":"8","author":"Deshpande","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1053\/j.semdp.2011.02.010_bib55","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.onc.1208299","article-title":"Destabilization of cyclin D1 message plays a critical role in cell cycle exit upon mitogen withdrawal","volume":"24","author":"Guo","year":"2004","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2011.02.010_bib56","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2141.1999.01314.x","article-title":"Molecular analysis of bcl-1\/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation","volume":"105","author":"Stamatopoulos","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib57","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"key":"10.1053\/j.semdp.2011.02.010_bib58","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/leu.2009.31","article-title":"t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals","volume":"23","author":"Lecluse","year":"2009","journal-title":"Leukemia"},{"issue":"suppl 1","key":"10.1053\/j.semdp.2011.02.010_bib59","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/cyto.b.20543","article-title":"Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic\/genetic characteristics","volume":"78","author":"Nieto","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1053\/j.semdp.2011.02.010_bib60","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2007.02906.x","article-title":"In-situ mantle cell lymphoma\u2014a report of two cases","volume":"52","author":"Aqel","year":"2008","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.02.010_bib61","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-10-299628","article-title":"How to diagnose and manage \u201cin situ\u201d lymphoma","author":"Carbone","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U","article-title":"Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma","volume":"21","author":"Monni","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib63","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood.V93.4.1372","article-title":"Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features","volume":"93","author":"Cuneo","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib64","first-page":"594","article-title":"Secondary chromosome changes in mantle cell lymphoma","volume":"84","author":"Wlodarska","year":"1999","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib65","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib66","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","article-title":"Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling","volume":"113","author":"Bea","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.0.CO;2-M","article-title":"t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia","volume":"27","author":"Bentz","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib68","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood.V98.12.3479","article-title":"Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma","volume":"98","author":"Martinez-Climent","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2141.2002.03260.x","article-title":"Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization","volume":"116","author":"Allen","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib70","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood-2004-07-2730","article-title":"Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization","volume":"105","author":"Schraders","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.20836","article-title":"High-resolution genomic screening in mantle cell lymphoma\u2014specific changes correlate with genomic complexity, the proliferation signature and survival","volume":"50","author":"Halldorsdottir","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib72","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2141.2008.07199.x","article-title":"Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis","volume":"142","author":"Katzenberger","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib73","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome","volume":"105","author":"Rubio-Moscardo","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib74","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib75","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib76","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib77","first-page":"699","article-title":"Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma","volume":"36","author":"Stefancikova","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib78","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood.V86.8.2892.2892","article-title":"p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)","volume":"86","author":"Louie","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib79","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.1996.5421085.x","article-title":"Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome","volume":"93","author":"Zoldan","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib80","first-page":"1010","article-title":"Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities","volume":"12","author":"Moller","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib81","first-page":"1141","article-title":"p53 and mdm2 in mantle cell lymphoma in leukemic phase","volume":"87","author":"Solenthaler","year":"2002","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib82","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","article-title":"CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus","volume":"65","author":"Hernandez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib83","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.10891","article-title":"Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309","volume":"92","author":"Hartmann","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib84","first-page":"2409","article-title":"BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas","volume":"61","author":"Bea","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib85","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib86","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.leukres.2006.10.022","article-title":"Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma","volume":"31","author":"Flordal-Thelander","year":"2007","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib87","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10428190701817282","article-title":"Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.02.010_bib88","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.exphem.2009.04.012","article-title":"Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array","volume":"37","author":"Kawamata","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib89","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib90","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2003-12-4175","article-title":"Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions","volume":"104","author":"Kohlhammer","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib91","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.2008.07334.x","article-title":"Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes","volume":"143","author":"Schraders","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib92","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.12330","article-title":"Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization","volume":"93","author":"Sander","year":"2008","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib93","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-008-0686-2","article-title":"Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation","volume":"88","author":"Hutter","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib94","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1080\/10428190410001711479","article-title":"Burkitt transformation of mantle cell lymphoma","volume":"45","author":"Felten","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.02.010_bib95","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/10428190701852024","article-title":"Blastic mantle cell lymphoma with a Burkitt translocation","volume":"49","author":"Reddy","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.02.010_bib96","article-title":"Double hit B-cell lymphomas","author":"Aukema","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib97","first-page":"1225","article-title":"8q24 translocations in blastic transformation of mantle cell lymphoma","volume":"85","author":"Au","year":"2000","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.02.010_bib98","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/JQMR-323G-71Y9-M7MB","article-title":"Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities","volume":"116","author":"Onciu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib99","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib100","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","article-title":"Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations","volume":"101","author":"Camacho","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib101","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome","volume":"102","author":"Kienle","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib102","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib103","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2008.199","article-title":"Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity","volume":"22","author":"Schraders","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib104","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","article-title":"Somatic hypermutation and V(H) gene usage in mantle cell lymphoma","volume":"68","author":"Thorselius","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib105","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","article-title":"Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma","volume":"101","author":"Walsh","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib106","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/10428190801947559","article-title":"Molecular genetic characterization reveals new subsets of mantle cell lymphoma","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.02.010_bib107","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/path.1727","article-title":"Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms","volume":"205","author":"Carreras","year":"2005","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib108","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/modpathol.3800237","article-title":"Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes","volume":"18","author":"Thelander","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib109","first-page":"4398","article-title":"Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells","volume":"62","author":"Ek","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Rizzatti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib111","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V98.3.787","article-title":"Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray","volume":"98","author":"Hofmann","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib112","first-page":"8226","article-title":"The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival","volume":"63","author":"Martinez","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib113","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma","volume":"132","author":"Rinaldi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib114","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.leu.2403057","article-title":"High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of cyclin D1 in mantle cell lymphoma","volume":"17","author":"Islam","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.02.010_bib115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.leu.2403293","article-title":"Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma","volume":"18","author":"Schmechel","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.02.010_bib116","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib117","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2141.2002.03931.x","article-title":"Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma","volume":"119","author":"Zhu","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib118","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2172-10-2","article-title":"High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes","volume":"10","author":"Mahshid","year":"2009","journal-title":"BMC Immunol"},{"key":"10.1053\/j.semdp.2011.02.010_bib119","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1074\/mcp.M800515-MCP200","article-title":"Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma","volume":"8","author":"Boyd","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1053\/j.semdp.2011.02.010_bib120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajpath.2010.11.033","article-title":"Arachidonate 5-lipoxygenase establishes adaptive humoral immunity by controlling primary B cells and their cognate T-cell help","volume":"178","author":"Nagashima","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib121","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2007.12.008","article-title":"The endocannabinoid system in cancer-Potential therapeutic target?","volume":"18","author":"Flygare","year":"2007","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2011.02.010_bib122","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biocel.2009.07.018","article-title":"Critical roles for SoxC transcription factors in development and cancer","volume":"42","author":"Penzo-Mendez","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/j.semdp.2011.02.010_bib123","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ncomms1008","article-title":"Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors","volume":"1","author":"Bhattaram","year":"2010","journal-title":"Nat Commun"},{"key":"10.1053\/j.semdp.2011.02.010_bib124","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","article-title":"Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib125","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1158\/0008-5472.CAN-09-2006","article-title":"Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation","volume":"69","author":"Hide","year":"2009","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.02.010_bib126","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ejca.2009.01.028","article-title":"The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer","volume":"45","author":"Brennan","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semdp.2011.02.010_bib127","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0609.2002.01677.x","article-title":"Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma","volume":"69","author":"Raty","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib128","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.leu.2403387","article-title":"Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome","volume":"18","author":"Schrader","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.02.010_bib129","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones","volume":"89","author":"Ott","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib131","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/10428194.2010.540361","article-title":"Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus","volume":"52","author":"Vela-Chavez","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.02.010_bib132","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","article-title":"Molecular pathogenesis and a consequent classification of multiple myeloma","volume":"23","author":"Bergsagel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib133","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.annonc.a010568","article-title":"Involvement of the CCND1 gene in hairy cell leukemia","volume":"7","author":"de Boer","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2011.02.010_bib134","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","author":"Brunetti","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.02.010_bib135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"CD200 (OX-2 membrane glycoprotein) expression in B cell-derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.02.010_bib136","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Moreaux","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib137","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.02.010_bib138","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","volume":"23","author":"Metcalf","year":"2010","journal-title":"Mod Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T16:17:07Z","timestamp":1712593027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257011000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":138,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0740257011000153"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2011.02.010","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}